e-learning
resources
Vienna 2012
Monday, 03.09.2012
GOLD guidelines 2011: new assessment of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics of GOLD 2011 grading system in the COPDGene cohort
M. Han, M. Dransfield, D. Curran-Everett, A. Anzueto, F. Martinez, E. Silverman, J. Crapo, G. Washko, B. Make (Ann Arbor, Birmingham, Denver, Boston, San Antonio, United States Of America)
Source:
Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Session:
GOLD guidelines 2011: new assessment of COPD
Session type:
Oral Presentation
Number:
1646
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Han, M. Dransfield, D. Curran-Everett, A. Anzueto, F. Martinez, E. Silverman, J. Crapo, G. Washko, B. Make (Ann Arbor, Birmingham, Denver, Boston, San Antonio, United States Of America). Characteristics of GOLD 2011 grading system in the COPDGene cohort. Eur Respir J 2012; 40: Suppl. 56, 1646
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Source: Eur Respir J 2013; 42: 636-646
Year: 2013
Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group
Source: International Congress 2017 – Notable abstracts in asthma
Year: 2017
GOLD classifications and mortality in COPD: The HUNT study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
GOLD classification of COPD and subsequent mortality: findings from a cohort study
Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Year: 2004
FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Source: Eur Respir J 2013; 42: 1391-1401
Year: 2013
COPD severity using GOLD 2017 in real life: The French Palomb Cohort
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification
Source: Eur Respir J 2013; 42: 647-654
Year: 2013
An Italian, observational, multicenter trial to describe the therapeutic approach according to COPD GOLD guidelines during three years of observation: The MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
GOLD classification of COPD and incident lung cancer: findings from a cohort study
Source: Eur Respir J 2004; 24: Suppl. 48, 269s
Year: 2004
Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Characteristics and longitudinal progression of COPD GOLD B
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept